FDA Inspection 1263423 — RECORDATI RARE DISEASES INC.
The FDA completed an inspection of RECORDATI RARE DISEASES INC. on February 21, 2025 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgewater, NJ (United States)
Additional Details
Sponsor, Contract Research Organization